Perfalgan and haemolytic anaemia Patient Reports February 10, 2012

Perfalgan Side Effects Report #4716050-1
Perfalgan side effect was reported by a Health Professional from FRANCE on May 19, 2005. Male patient, 65 years of age, weighting 138.9 lb, was treated with Perfalgan. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, cholestasis, convulsion, gamma-glutamyltransferase increased, haemolytic anaemia, overdose. Perfalgan dosage: unknown. During the same period patient was treated with AMIKLIN, DEPAKENE, CALCIPARINE, TAZOCILLINE, TRIFLUCAN, NEORECORMON, LASIX, CALCIDIA. Patient was hospitalized. Patient died on 05/22/2005.